Search Results - "Sarafanov, Andrey G."

Refine Results
  1. 1

    Plasma Clearance of Coagulation Factor VIII and Extension of Its Half-Life for the Therapy of Hemophilia A: A Critical Review of the Current State of Research and Practice by Sarafanov, Andrey G

    “…Factor VIII (FVIII) is an important component of blood coagulation as its congenital deficiency results in life-threatening bleeding. Current prophylactic…”
    Get full text
    Journal Article
  2. 2

    Isolated Variable Domains of an Antibody Can Assemble on Blood Coagulation Factor VIII into a Functional Fv-like Complex by Shestopal, Svetlana A., Parunov, Leonid A., Olivares, Philip, Chun, Haarin, Ovanesov, Mikhail V., Pettersson, John R., Sarafanov, Andrey G.

    “…Single-chain variable fragments (scFv) are antigen-recognizing variable fragments of antibodies (FV) where both subunits (VL and VH) are connected via an…”
    Get full text
    Journal Article
  3. 3

    Cluster III of Low-Density Lipoprotein Receptor-Related Protein 1 Binds Activated Blood Coagulation Factor VIII by Kurasawa, James H, Shestopal, Svetlana A, Woodle, Samuel A, Ovanesov, Mikhail V, Lee, Timothy K, Sarafanov, Andrey G

    Published in Biochemistry (Easton) (20-01-2015)
    “…Low-density lipoprotein receptor-related protein 1 (LRP) mediates clearance of blood coagulation factor VIII (FVIII). In LRP, FVIII binds the complement-type…”
    Get full text
    Journal Article
  4. 4

    Mapping the Binding Region on the Low Density Lipoprotein Receptor for Blood Coagulation Factor VIII by Kurasawa, James H., Shestopal, Svetlana A., Karnaukhova, Elena, Struble, Evi B., Lee, Timothy K., Sarafanov, Andrey G.

    Published in The Journal of biological chemistry (26-07-2013)
    “…Low density lipoprotein receptor (LDLR) was shown to mediate clearance of blood coagulation factor VIII (FVIII) from the circulation. To elucidate the…”
    Get full text
    Journal Article
  5. 5

    Analysis of iron, zinc, selenium and cadmium in paraffin-embedded prostate tissue specimens using inductively coupled plasma mass-spectrometry by Sarafanov, Andrey G., Todorov, Todor I., Kajdacsy-Balla, André, Gray, Marion A., Macias, Virgilia, Centeno, José A.

    “…Formalin-fixed paraffin-embedded (FFPE) tissue specimens represent a valuable and abundant resource of pathologic material for various biomedical studies. In…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Characterization of protein unable to bind von Willebrand factor in recombinant factor VIII products by Chun, Haarin, Pettersson, John R., Shestopal, Svetlana A., Wu, Wells W., Marakasova, Ekaterina S., Olivares, Philip, Surov, Stepan S., Ovanesov, Mikhail V., Shen, Rong‐Fong, Sarafanov, Andrey G.

    Published in Journal of thrombosis and haemostasis (01-04-2021)
    “…Background Therapeutic products with coagulation factor VIII (FVIII) have a wide range of specific activities, implying presence of protein with altered…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Prostate cancer outcome and tissue levels of metal ions by Sarafanov, Andrey G., Todorov, Todor I., Centeno, José A., Macias, Virgilia, Gao, Weihua, Liang, Wei-Min, Beam, Craig, Gray, Marion A., Kajdacsy-Balla, André A.

    Published in The Prostate (01-08-2011)
    “…BACKGROUND There are several studies examining prostate cancer and exposure to cadmium, iron, selenium, and zinc. Less data are available on the possible…”
    Get full text
    Journal Article
  12. 12

    Insect cell-based expression and characterization of a single-chain variable antibody fragment directed against blood coagulation factor VIII by Kurasawa, James H., Shestopal, Svetlana A., Jha, Naveen K., Ovanesov, Mikhail V., Lee, Timothy K., Sarafanov, Andrey G.

    Published in Protein expression and purification (01-04-2013)
    “…A recombinant single-chain variable antibody fragment (scFv) KM33 was previously described as a ligand that can inhibit the function of blood coagulation…”
    Get full text
    Journal Article
  13. 13

    Identification of Coagulation Factor VIII A2 Domain Residues Forming the Binding Epitope for Low-Density Lipoprotein Receptor-Related Protein by Sarafanov, Andrey G, Makogonenko, Evgeny M, Pechik, Igor V, Radtke, Klaus-Peter, Khrenov, Alexey V, Ananyeva, Natalya M, Strickland, Dudley K, Saenko, Evgueni L

    Published in Biochemistry (Easton) (14-02-2006)
    “…Regulation of the coagulation factor VIII (fVIII) level in circulation involves a hepatic receptor low-density lipoprotein receptor-related protein (LRP). One…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Role of Activation of the Coagulation Factor VIII in Interaction with vWf, Phospholipid, and Functioning within the Factor Xase Complex by Saenko, Evgueni L, Shima, Midori, Sarafanov, Andrey G

    Published in Trends in Cardiovascular Medicine (01-10-1999)
    “…Blood coagulation factor VIII (fVIII) in its nonactivated form circulates in plasma in a complex with von Willebrand factor (vWf). Upon activation by thrombin-…”
    Get full text
    Book Review Journal Article
  16. 16

    Characterization of Interaction of Factor VIII with Engineered Variants of a Single-Chain Variable Antibody Fragment by Shestopal, Svetlana A, Parunov, Leonid A, Ovanesov, Mikhail V, Lee, Timothy K, Sarafanov, Andrey G

    Published in Blood (29-11-2018)
    “…Introduction Replacement therapy for Hemophilia A requires frequent infusions of Factor VIII (FVIII) due to its relatively short half-life of ~12 h in plasma…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Von Willebrand Factor A1 Domain Binds to Clusters II and IV of Low-Density Lipoprotein Receptor-Related Protein 1 by Uceda Cortez, Gabriela, Shestopal, Svetlana A, Kurasawa, James H, Lee, Timothy K, Sarafanov, Andrey G

    Published in Blood (08-12-2017)
    “…Introduction. Von Willebrand factor (VWF) is a large multimeric plasma glycoprotein involved in hemostasis and thrombosis. Genetic and in vivo studies have…”
    Get full text
    Journal Article
  19. 19

    Characterization of Protein Unable to Bind Von Willebrand Factor in Recombinant Factor VIII Products: Can We Reduce Their Immunogenicity? by Chun, Haarin, Pettersson, John R, Shestopal, Svetlana A, Wu, Wells W, Marakasova, Ekaterina S, Olivares, Philip, Surov, Stepan S, Ovanesov, Mikhail V, Shen, Rong-Fong, Lee, Timothy K, Sarafanov, Andrey G

    Published in Blood (05-11-2020)
    “…Introduction Therapeutic products with blood coagulation factor VIII (FVIII) have a wide range of protein contents per activity unit (or IU/mg, specific…”
    Get full text
    Journal Article
  20. 20

    Structural and Functional Characterization of a Codon Optimized Coagulation Factor VIII by Shestopal, Svetlana A, Kurasawa, James H, Hao, Jian-Jiang, Karnaukhova, Elena, Liang, Yideng, Lin, Min, Ovanesov, Mikhail V, Lee, Timothy K, McVey, John H, Sarafanov, Andrey G

    Published in Blood (02-12-2016)
    “…Background. Production of recombinant factor VIII (FVIII) is challenging due to its low expression. Previously, it was shown that codon optimization of a B…”
    Get full text
    Journal Article